Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Midazolam for Patient Satisfaction in PTA
NCT02929095Completed
- Sponsor
- Yonsei University
- Start
- Oct 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in peripheral arterial occlusive disease (PAOD) (2 arms), sponsored by Yonsei University. Primary endpoint: Patient's satisfaction at 24 hours. Started Oct 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
peripheral arterial occlusive disease (PAOD)
Beyond the preview
Go deeper on NCT02929095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02929095.